FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 360:2792-2793 June 25, 2009 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Glickman, S. W. PubMed Citation

To the Editor: In their article, Glickman et al. (Feb. 19 issue)¹ examine the growing phenomenon of clinical trials being conducted outside the regulatory framework of the developed world. They rightfully point out some of the ethical and scientific pitfalls of these investigations. However, they do not mention that the offshoring of clinical studies can also deprive critically ill patients in the developed world access to some of the latest drugs and devices, the underlying basic research for which was paid for through taxes by these same persons. Perhaps this issue, as opposed to paternalistic concerns about inadequate regulation within . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.